Medicare Part D Redesign: Pfizer’s Catastrophic Phase Discounts Will Total $1.5bn In 2025

The new discount obligation will more than offset the increased sales expected to be driven by the redesign's $2,000 cap on beneficiary spending. The forecast is the first public discussion of the Part D redesign's impact on an individual company.